GSK3B and metabolic syndrome: Also, a genetic mutation of the Gys inhibiting enzyme Gsk3β (that renders Gsk3β resistant to IIS inhibition) corrected diabetes in mouse models of insulin resistance (Tanabe et al., 2008) and protected against metabolic syndrome (Chen et al., 2016).